Paper11057794
Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
Ververs TF and 6 others. Crit Care Med, 2000. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration. Papers, record 11057794. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11057794
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acute Kidney Injury | Major topic |
| Bacterial Infections | Major topic |
| Hemofiltration | Major topic |
| Thienamycins | Major topic |
| Adult | |
| Critical Illness | |
| Drug Monitoring | |
| Female | |
| Humans | |
| Infusions, Intravenous | |
| Least-Squares Analysis | |
| Male | |
| Meropenem | |
| Metabolic Clearance Rate | |
| Middle Aged | |
| Prospective Studies | |
| Time Factors | |
| Tissue Distribution |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 11505159 | Meropenem and continuous renal replacement. | https://conductscience.org/library/papers/11505159 |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42730518 | Integrating CRRT as a Virtual Organ Into Physiologically Based Pharmacokinetic Modeling to Optimize Antimicrobial Dosing in Septic Patients. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42730518 | PubMed |
| 41792368 | Development and validation of a machine learning model for individualised meropenem dosing in CRRT patients. | Sci Rep | 2026 | https://conductscience.org/library/papers/41792368 | PubMed |
| 36005753 | Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/36005753 | PubMed |
| 34773921 | Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno-venous haemofiltration. | Br J Clin Pharmacol | 2022 | https://conductscience.org/library/papers/34773921 | PubMed |
| 32323030 | Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study. | Ann Intensive Care | 2020 | https://conductscience.org/library/papers/32323030 | PubMed |
| 32046092 | Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. | Pharmacy (Basel) | 2020 | https://conductscience.org/library/papers/32046092 | PubMed |
| 31814045 | The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF). | Eur J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31814045 | PubMed |
| 31157005 | Individualised antimicrobial dosing in critically ill patients undergoing continuous renal replacement therapy: focus on total drug clearance. | Eur J Hosp Pharm | 2018 | https://conductscience.org/library/papers/31157005 | PubMed |
| 30094712 | A Robust Statistical Approach to Analyse Population Pharmacokinetic Data in Critically Ill Patients Receiving Renal Replacement Therapy. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/30094712 | PubMed |
| 26997934 | Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report. | J Pediatr Pharmacol Ther | 2016 | https://conductscience.org/library/papers/26997934 | PubMed |
| 25881576 | A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. | Crit Care | 2015 | https://conductscience.org/library/papers/25881576 | PubMed |
| 25042938 | Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. | Crit Care | 2014 | https://conductscience.org/library/papers/25042938 | PubMed |
| 24886826 | β-lactam antibiotic concentrations during continuous renal replacement therapy. | Crit Care | 2014 | https://conductscience.org/library/papers/24886826 | PubMed |
| 23675445 | Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1). | PLoS One | 2013 | https://conductscience.org/library/papers/23675445 | PubMed |
| 22839761 | Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review. | Ann Intensive Care | 2012 | https://conductscience.org/library/papers/22839761 | PubMed |
| 21649882 | Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. | Crit Care | 2011 | https://conductscience.org/library/papers/21649882 | PubMed |
| 21343897 | Antibiotic dosing in critically ill patients with acute kidney injury. | Nat Rev Nephrol | 2011 | https://conductscience.org/library/papers/21343897 | PubMed |
| 20479205 | Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20479205 | PubMed |
| 19040780 | Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury. | Crit Care | 2008 | https://conductscience.org/library/papers/19040780 | PubMed |
| 18307371 | Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy. | Clin Pharmacokinet | 2008 | https://conductscience.org/library/papers/18307371 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11057794
GET https://conductscience.org/api/papers/v1/11057794/cited_by?page=2